Hartmut H. Malluche

University of Kentucky — United States

Medicine · Health Sciences

62h-index21.3kcitations243works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parathyroid Disorders and Treatments(114), Bone health and osteoporosis research(60), Bone health and treatments(58), Vitamin D Research Studies(45), Bone Metabolism and Diseases(22)

Publications243 total

Familial complete pachydermoperiostosis presenting with vertebral hypertrophy and myelopathy
JBMR Plus·2025Open Access
Bone disease and osteoporosis associated with Pompe disease
JBMR Plus·2025· 1 citedOpen Access
ADAM: automated digital phenotyping and morphological texture analysis of bone biopsy images using deep learning
JBMR Plus·2025· 1 citedOpen Access
Kidney function, bone health, and vascular calcifications in patients with CKD II – IV: A 2 – 3 year prospective study with bone biopsies
Clinical Nephrology·2025· 1 cited
Presence and Progression of Changes in Bone Mass, Bone Quality, and Vascular Calcifications in Patients with Moderate to Advanced Reduction in Kidney Function
Journal of the American Society of Nephrology·2024
Celebrating 50-years: the history and future of the International Society of Bone Morphometry
JBMR Plus·2024· 5 citedOpen Access
In chronic kidney disease altered cardiac metabolism precedes cardiac hypertrophy
American Journal of Physiology-Renal Physiology·2024· 5 citedOpen Access
Bone Disease Related to Severe Vitamin D Deficiency in an Adult
Journal of the American Society of Nephrology·2023
Bone and Vascular Changes in CKD-MBD over 2 to 3 Years Analyzed by Artificial Intelligence
Journal of the American Society of Nephrology·2023
In the CKD-MBD Absent Vascular Disease, CKD Decreases Cardiac Mitochondrial Function and Activin A Is an Activator of Skeletal Activin Receptor Signaling
Journal of the American Society of Nephrology·2023
Renal osteodystrophy: something old, something new, something needed
Current Opinion in Nephrology & Hypertension·2023· 14 citedOpen Access
Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy
Journal of Clinical Investigation·2023· 16 citedOpen Access
FGF-23 and sclerostin in serum and bone of CKD patients
Clinical Nephrology·2023· 16 citedOpen Access
Changes in Bone Quality Over 2 Years in Patients With CKD Stages 2-4
Journal of the American Society of Nephrology·2022
Treatment of bone loss in CKD5D: Better survival in patients with non-high bone turnover
Clinical Nephrology·2022· 8 cited
Trabecular bone microcrack accumulation in patients treated with bisphosphonates for durations up to 16 years
Journal of Orthopaedic Research®·2022· 3 citedOpen Access
Prevalence of low bone formation in untreated patients with osteoporosis
PLoS ONE·2022· 9 citedOpen Access
The Role of Alterations in Alpha-Klotho and FGF-23 in Kidney Transplantation and Kidney Donation
Frontiers in Medicine·2022· 10 citedOpen Access
Response to “Low Turnover Bone Disease in Early CKD Stages”
Kidney International Reports·2022Open Access
Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD
Kidney International Reports·2022· 22 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Marie‐Claude Monier‐Faugere(15), Marie–Claude Faugere(8), Shaul G. Massry(5), Marie-Claude Monier-Faugere(4), Hanna Mawad(4), Johann Herberth(4), Keith A. Hruska(3), M.-C. Faugere(3), Clifford J. Rosen(3), Thomas L. Clemens(3), M. Chris Langub(3), Zhaopo Geng(3), Eberhard Ritz(3), Aníbal Ferreira(3), Quanle Qi(3), Robert M. Friedler(3), Nicholas J. Koszewski(3), Paolo Fanti(3), A. M. Parfitt(2), Marc K. Drezner(2)